Sign In
Buy ZTS
$74.17
-1.16 (-1.54%)
At Close: Jul 22, 2026
Zoetis Announces Third Quarter 2025 Results
07:00am, Tuesday, 04'th Nov 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2025. The company reported revenue of $2.4 billion for th
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) today announced that following a 10-year distinguished career dedicated to advancing veterinary medicine and innovatio
Zoetis: High-Quality Compounder For Patient Long-Term Dividend Growth Investors
09:30am, Monday, 03'rd Nov 2025
Zoetis is a US-based company involved in the discovery, development, manufacture, and marketing of animal medicines and vaccines. ZTS has increased its dividend for 13 consecutive years. This streak
2 Magnificent Dividend Stocks to Buy and Hold Forever
09:15am, Sunday, 02'nd Nov 2025
Investing in strong dividend stocks is a great way to earn better-than-average long-term returns. AbbVie has a reliable, non-cyclical business and a long and impressive track record of dividend growth
Buy Zoetis Stock Today?
10:10am, Friday, 31'st Oct 2025
Zoetis (ZTS) stock warrants your attention. Why? Because it offers high margins – indicative of pricing power and the ability to generate cash – at a discounted price.
Seeking Clues to Zoetis (ZTS) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:16am, Thursday, 30'th Oct 2025
Besides Wall Street's top-and-bottom-line estimates for Zoetis (ZTS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart
Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect
02:50pm, Wednesday, 29'th Oct 2025
ZTS is poised for another earnings beat as rising demand for companion animal products like Simparica Trio and Apoquel drives expected Q3 revenue growth.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Portela becomes first mAb therapy with a three-month dosing interval approved for the alleviation of pain associated with OA in cats.
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
11:01am, Tuesday, 28'th Oct 2025
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis Appoints Stephanie Tilenius to its Board of Directors
08:30am, Tuesday, 28'th Oct 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) today announced the appointment of Stephanie Tilenius to its Board of Directors, effective as of December 1, 2025. Ms.
Zoetis (ZTS) Ascends But Remains Behind Market: Some Facts to Note
07:16pm, Monday, 27'th Oct 2025
Zoetis (ZTS) concluded the recent trading session at $147.53, signifying a +1.09% move from its prior day's close.
GRFS vs. ZTS: Which Stock Is the Better Value Option?
12:41pm, Monday, 27'th Oct 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their bu
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Tuesday, 21'st Oct 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Zoetis Stock: Outlook Remains Muted
06:48am, Tuesday, 21'st Oct 2025
Zoetis Inc. (NYSE:ZTS) is currently in its final 18th phase of the Adhishthana cycle on the weekly charts. Having formed a poor triad structure, the stock's outlook doesn't look encouraging.
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
07:00am, Wednesday, 15'th Oct 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Lenivia approval by Health Canada marks major milestone in the company's continued innovation for canine OA pain.
